ArticleCancers2018

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Johanna Buchroithner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.